跳至主要内容
临床试验/CTRI/2021/01/030318
CTRI/2021/01/030318Other未知

A Single-Center, Open-Label, Prospective, Clinical Validation Study of TROPCHEK â?? a Novel, Non-Invasive Class C In-Vitro Point-Of-Care Diagnostic Medical Device for detection of Cardiac Troponins T and I in the Venous Blood

Rohit Srivastava0 个研究点目标入组 53 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Leftover plasma from venous blood of suspected/ at-risk patients with ACS, COVID-19 and other conditions for which testing for cardiac troponins are requested by physicians.
  • a) Acute coronary syndrome
  • b) Acute respiratory infection
  • c) COVID-19
  • d) Pulmonary hypertension
  • e) Pulmonary embolus
  • f) Congestive heart failure
  • g) Coronary artery spasm
  • h) Tachyarrhythmias
  • i) Myocarditis
  • j) Kidney disease
  • k) Prolonged exercise
  • l) Trauma that injures the heart
  • m) Cardiomyopathy
  • n) Cardiac angioplasty/stenting
  • o) Heart defibrillation or electrical cardioversion
  • p) Open heart surgery
  • q) Radiofrequency ablation of the heart
  • r) Rhabdomyolysis and polymyositis

排除标准

  • a) Patients not willing to participate in the study
  • b) Specimen prepared incorrectly
  • c) Those with labelling problems
  • d) Temperature not maintained for specimen.
  • e) Samples received >4 hours after collection.

研究者

发起方
Rohit Srivastava

相似试验